Formulation approaches in enhancement of patient compliance to oral drug therapy

Bibliography

• Ngoh LN. Health literacy: a barrier to pharmacist-patient communication and medication adherence. J Am Pharm Assoc 2009;49(5):e132-46
   Google Scholar
• Elliott RA, Marriott JL. Standardized assessment of patients' capacity to manage medications: a systematic review of published instruments. BMC Geriatr 2009;9:27
   PubMedGoogle Scholar
• Mattar ME, Markello J, Yaffe SJ. Pharmaceutic factors affecting pediatric compliance. Pediatrics 1975;55:101-8
   PubMed Web of Science ®Google Scholar
• Boreham PFL, Benrimoj S, Ong M, A compliance study in pediatric patients receiving treatment for giardiasis. Aust J Hosp Pharm 1986;16:138-42
   Google Scholar
• Fincham JE. Patient compliance in the ambulatory elderly: a review of the literature. J Geriatr Drug Ther 1988;2(4):31-52
   Google Scholar
• Goldfarb J, Patel J, Wormser G. Antimicrobial flavors: a consideration in drug compliance. Drug Ther 1986;2:59-71
   Google Scholar
• Weinstein AG. Clinical management strategies to maintain drug compliance in asthmatic children. Ann Allergy Asthma Immunol 1995;74:304-10
   PubMed Web of Science ®Google Scholar
• Fennell RS, Foulkes L-M, Boggs SR. Family-based program to promote medication compliance in renal transplant children. Transplant Proc 1994;26:102-3
   PubMed Web of Science ®Google Scholar
• Nunn T, Williams J. Formulation of medicines for children. Br J Clin Pharmacol 2005;59(6):674-6
   PubMed Web of Science ®Google Scholar
• Kumazawa T, Nomura T, Kurihara K. Liposomes as model for taste cells: receptor sites for bitter substances including N–C S substances and mechanism of membrane potential changes. Biochemistry 1988;27:1239-44
   PubMed Web of Science ®Google Scholar
• Sugao H, Yamazaki S, Shiozawa H, Yano K. Taste masking of bitter drug powder without loss of bioavailability by heat treatment of wax-coated microparticles. J Pharm Sci 1998;87:96-100
   PubMed Web of Science ®Google Scholar
• Hashimoto Y, Tanaka M, Kishimoto H, Preparation, characterization and taste-masking properties of polyvinylacetal diethylaminoacetate microspheres containing trimebutine. J Pharm Pharmacol 2002;54:1323-8
   PubMed Web of Science ®Google Scholar
• Nanda A, Kandarapu R, Garg S. An update on taste masking technologies for oral pharmaceuticals. Indian J Pharm Sci 2002;64:10-17
   Google Scholar
• Keast RSJ, Breslin PAS. Bitterness suppression with zinc sulfate and Nacclamate: a model of combined peripheral and central neural approaches to flavor modification. Pharm Res 2005;22:1970-7
   PubMed Web of Science ®Google Scholar
• Fu Y, Yang S, Jeong SH, Critical reviews™ in therapeutic drug carrier systems. Crit Rev Ther Drug 2004;21(6):433-75; Orally Fast Disintegrating Tablets: Developments, Technologies, Taste-Masking and Clinical Studies
   PubMed Web of Science ®Google Scholar
• Kleinert HD, Baker WR, Stein HH. Ion exchange resin complexes: an approach to mask the taste of bitter drugs. Pharm Technol 1993;17:30
   Google Scholar
• Douroumis D. Practical approaches of taste masking technologies in oral solid forms. Expert Opin Drug Deliv 2007;4(4):417-26
   PubMed Web of Science ®Google Scholar
• Anderson O, Zweidorff OK, Hjelde T. Problems when swallowing tablets. A questionnaire study from general practice [in Norwegian]. Tidsskr Nor Laegeforen 1995;20:947-9
   Google Scholar
• Slowson M, Slowson S. What to do when patients cannot swallow their medications. Pharm Times 1985;51:90-6
   Google Scholar
• Lindgren S, Janzon L. Dysphagia: prevalence of swallowing complaints and clinical findings. Med Clin N Am 1993;77:3-5
   Google Scholar
• Chang RK, Guo X, Burnside BA. Fast-dissolving tablets. Pharm Technol 2000;24(6):52-8
   Google Scholar
• Rathbone MJ, Drummond BK, Tucker IG. The oral cavity as a site for systemic drug delivery. Adv Drug Deliv Rev 1994;13:1-22
   Web of Science ®Google Scholar
• Rhodus NL, Schuh MJ. Effects of pilocarpine on salivary flow in patients with Sj€ogren's syndrome. Oral Surg Oral Med Oral Pathol 1991;72:545-9
   PubMedGoogle Scholar
• Gmunder CB, Li W, Ream R, Sildenafil chewing gum formulations and methods of using the same. US6592850B2; 2003
   Google Scholar
• Liang AC, Chen LH. Fast-dissolving intraoral drug delivery systems. Expert Opin Ther Patents 2001;11(6):981-6
   Web of Science ®Google Scholar
• Brown D. Orally disintegrating tablets: taste over speed. Drug Deliv Technol 2003;3(6):58; 61.13
   Google Scholar
• Ghosh TK, Pfister WR. Drug delivery to the oral cavity: molecules to market. Marcel Dekker, Inc.; New York: 2005
   Google Scholar
• Seager H. Drug delivery products and Zydis® fast dissolving dosage form. Presented at the British Pharmaceutical Conference; September 1997; Scarborough
   Google Scholar
• Yarwood R. Oral fast dissolving dosage form technologies. Presented at IBC symposium on drug delivery systems; July 17 − 18, 1997; San Francisco
   Google Scholar
• Wehling F, Schuehle S. Base coated acid particles and effervescent formulations incorporating same. US5503846, 1993
   Google Scholar
• Wehling F, Schuehle S, Madamala N. Pediatric effervescent dosage. US5223264, 1991
   Google Scholar
• Fu Y, Yang S, Jeong SH, Orally fast disintegrating tablets: developments, technologies, tastemasking and clinical studies. Crit Rev Ther Drug Carrier Syst 2004;21:433-76
   PubMed Web of Science ®Google Scholar
• Khan S, Kataria P, Nakhat P, Yeole P. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapidly disintegrating tablets. AAPS PharmSciTech 2007;8:article 46
   PubMedGoogle Scholar
• William N. Anti-infective. In: Gennaro AR, editors. Remington's: the Science and Practice of Pharmacy. Volume 2 Lippincott Williams and Wilkins; Philadelphia, PA: 1547
   Google Scholar
• Khan S, Kataria P, Nakhat P, Yeole P. Taste masking of ondensetron hydrochloride by polymer carrier system and formulation of rapidly disintegrating tablets. AAPS PharmSciTech 2007;8:article 46
   PubMedGoogle Scholar
• Fu Y, Yang S, Jeong SH, Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies. Crit Rev Ther Drug Carrier Syst 2004;21:433-76
   PubMed Web of Science ®Google Scholar
• Shah PP, Mashru RC. Development and evaluation of artemether taste masked rapid disintegrating tablets with improved dissolution using solid dispersion technique. AAPS PharmSciTech 2008;9:494-500
   PubMed Web of Science ®Google Scholar
• Shah PP, Rajashree C. Mashru formulation and evaluation of primaquine phosphate taste-masked rapidly disintegrating tablet. J Pharm Pharmacol 2008;60:1279-85
   PubMed Web of Science ®Google Scholar
• Dinge A, Nagarsenker M. Formulation and evaluation of fast dissolving films for delivery of Triclosan to the oral cavity. AAPS PharmSciTech 2008;9(2):349-56
   PubMed Web of Science ®Google Scholar
• Saigal N, Baboota S, Ahuja A, Ali J. Fast-dissolving Intraoral drug delivery systems. Expert Opin Ther Patents 2008;18(7):769-78
   Web of Science ®Google Scholar
• Habib W, Khankari R, Hontz J. Fast dissolve delivery system. Crit Rev Ther Drug Carrier Syst 2000;17:61-72
   PubMed Web of Science ®Google Scholar
• Biradar SS, Bhagavati ST, Kuppuasad IJ. Fast dissolving drug delivery systems: a brief overview. Internet J Pharmacol 2006;4:2
   Google Scholar
• Shimoda H, Taniguchi K, Nishimura M, Preparation of a fast dissolving oral thin film containing dexamethasone: a possible application to antiemesis during cancer chemotherapy. Eur J Pharm Biopharm 2009;73(3):361-5
   PubMed Web of Science ®Google Scholar
• Kelly F. Something for a sore throat please. Aust Pharm 2008;27:394-7
   Google Scholar
• Hartung-Brooks L. Sore throat. On Contin Pract 1990;17:2-6
   Google Scholar
• Fincham JE. Smoking cessation products, Chapter 36. In: Covington TR, editor. Handbook of Nonprescription Drugs. American Pharmaceutical Association; Washington, DC: 1996. p. 715-23
   Google Scholar
• Houtsmuller EJ, Fant RV, Eissenberg TE, Flavor® improvement does not increase abuse liability of nicotine chewing gum. Pharmacol Biochem Behav 2002;72(3):559-68
   PubMed Web of Science ®Google Scholar
• Christrup LL, Davis SS, Frier M, Deposition of a model substance, 99mTcE-HIDA, in the oral cavity after administration of lozenges, chewing gum and sublingual tablets. Int J Pharm 1990;66:169-74
   Web of Science ®Google Scholar
• Chaudhri S, Shahiwala A. Medicated chewing gums: a promising drug delivery system. Expert Opin Drug Deliv 2010;7(7):871-85
   PubMed Web of Science ®Google Scholar
• Richards RME, Cowie G, McCague GJ. In vivo investigations of the antibacterial activity of lozenges and mouthwashes on the aerobic bacterial flora of the mouth and throat. Pharm J 1989;6:58-63
   Google Scholar
• Richards RME, Xing DKL. In vitro evaluation of the antimicrobial activities of selected lozenges. J Pharm Sci 1993;82:1218-20
   PubMed Web of Science ®Google Scholar
• Stanley TH, Hague BH, Mock DL, Oral transmucosal fentanyl citrate (lollipop) premedication in human volunteers. Anaesth Analg 1989;69:21
   PubMed Web of Science ®Google Scholar
• Streisand JB, Stanley TH, Hague B, Oral transmucosal fentanyl citrate premedication in children. Anaesth Analg 1989;69:28
   PubMed Web of Science ®Google Scholar
• Friesen RH, Lockhart CH. Oral transmucosal fentanyl citrate for preanesthetic medication of pediatric day surgery patients with and without droperidol as a prophylactic anti-emetic. Anesthesiology 1992;76:46
   PubMed Web of Science ®Google Scholar
• Feld LH, Champeau MW, van Steennis CA, Preanesthetic medication in children: A comparison of oral transmucosal fentanyl citrate versus placebo. Anesthesiology 1989;71:374
   PubMed Web of Science ®Google Scholar
• Goldstein-Dresner MC, Davis PJ, Kretchman E, Double-blind comparison of oral transmucosal fentanyl citrate with oral meperidine, diazepam, and atropine as preanesthetic medication in children with congenital heart disease. Anesthesiology 1991;74:28
   PubMed Web of Science ®Google Scholar
• Kleinbloesem CH, van Brummelen P, van de Linde JA, Nifedipine: kinetics and dynamics in healthy subjects. Clin Pharmacol Ther 1984;35:742-9
   PubMed Web of Science ®Google Scholar
• Kleinbloesem CH, van Brummelen P, Danhof M, Rate of increase in plasma concentration of nifedipine as a major determinant of its haemodynamic effects in man. Clin Pharmacol Ther 1987;41:407-12
   PubMedGoogle Scholar
• Cramer JA, Lynch NO, Gaudin A-F, The effect of dosing frequency on compliance and persistence with bisphosphonate therapy in postmenopausal women: a comparison of Studies in the United States, the United Kingdom, and France. Clin Ther 2006;28(10):1686-94
   PubMed Web of Science ®Google Scholar
• Ritschel WA, Forusz H. Chronopharmacology: a review of drugs studies. Methods Find Exp Clin Pharmacol 1994;16(1):57-75
   PubMed Web of Science ®Google Scholar
• Lemmer B. Chronobiology, drug-delivery, and chronotherapeutics. Adv Drug Deliv Rev 2007;59:825-7
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Peppas NA. Chronobiology, drug delivery and chronotherapeutics. Adv Drug Deliv Rev 2007;59:828-51
   PubMed Web of Science ®Google Scholar
• Lemmer B. Chronopharmacology and controlled drug release. Expert Opin Drug Deliv 2005;2(4):667-81
   PubMedGoogle Scholar
• Mandal AS, Biswas N, Karim KM, Drug delivery system based on chronobiology–A review. J Control Release 2010;147(3):314-25
   PubMed Web of Science ®Google Scholar
• Janice M. Reichert trends in US approvals: new biopharmaceuticals and vaccines. Trends Biotechnol 2006;24(7):293-8
   PubMed Web of Science ®Google Scholar
• Walters KA. Drug delivery: topical and transdermal routes. In: Swarbrick J, editor. Encyclopedia of Pharmaceutical Technology. 3rd edition. Volume 1 Informa healthcare; New York: p. 1311-25, 2007
   Google Scholar
• Rogers K. Controlled release technology and delivery systems. Cosmet Toilet 1999;114(5):53-60
   Google Scholar
• Touitou E, Dayan N, Bergelson L, Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 2000;65:403-18
   PubMed Web of Science ®Google Scholar
• Tao L. Skin delivery from lipid vesicles. Cosmet Toilet 2000;115(4):43-50
   Google Scholar